Search Results | Showing 1 - 10 of 20 results for "AstraZeneca" |
| | ... foreign currency exposure hedged back to the Australian dollar. The top holdings in H100 are currently Shell, HSBC, and AstraZeneca. Betashares said the ETF provides diversification benefits in terms of both company exposure and industry sectors. Betashares ... |
| | | ... 2022 Meanwhile, healthcare has been a long-standing overweight for the Global Equity Fund portfolio. The fund had AstraZeneca PLC and health insurer Humana Inc in its top 10 portfolio holdings, as of 30 November 2022. "Healthcare is the ballast to the ... |
| | | ... and further efforts to match global standards. Examples of global firms partnering with Chinese businesses include AstraZeneca, Pfizer and Novartis, while Chinese firms such as BeiGene and Legend Biotech have also found multinational partners. "Authorities ... |
| | | ... to help its employees and their households in eight Sydney Local Government Areas (LGAs) to get the jab using the AstraZeneca vaccine. Designed in partnership with the federal government's COVID Shield Taskforce, the initiative provides onsite, workplace ... |
| | | ... distribution of the vaccine (especially among poorer nations) and most recently, anxiety over the linkage between the AstraZeneca vaccine and blood clots (which has prompted many governments to declare age-based bans on those receiving the vaccine). ... |
| | | ... Dreyfus Company (LDC) in Switzerland where she was global sustainability lead. She has also previously held roles at AstraZeneca, Proteus and Accenture. Originally from the UK, Cristina has significant international experience in sustainable agricultural ... |
| | | ... to identify the "magic number" needed to achieve herd immunity, but if three-out-of-five vaccines administered were AstraZeneca and the rest was Pfizer, then at least 75 per cent of the population needed to be jabbed. This number may even go up to 90 ... |
| | | ... it cannot provide substantial additional doses of its vaccine until late June or July... FT also discussed how the AstraZeneca candidate has been hit by manufacturing delays." If it's the same for Japan, it wouldn't be until the second half of ... |
| | | ... also added a new head of sales and business development in Allan McGregor. Previously at biopharmaceutical company AstraZeneca, McGregor bring 14 years' of sales experience. "We are lucky that a lot of really great people from the wealth management ... |
| | | ... business activity stoked fears over the timid economic recovery. Among London's biggest fallers were drugmakers Shire and AstraZeneca - both targeted by US takeovers this year - as Washington acted to curb so-called tax-inversion deals that sap government ... |
|